Published in J Exp Med on January 01, 1992
Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect Immun (1997) 2.46
Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun (1997) 2.26
Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect Immun (2005) 2.13
Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins. Infect Immun (2006) 1.67
Interleukin-12 production is required for chlamydial antigen-pulsed dendritic cells to induce protection against live Chlamydia trachomatis infection. Infect Immun (1999) 1.35
Chlamydia trachomatis native major outer membrane protein induces partial protection in nonhuman primates: implication for a trachoma transmission-blocking vaccine. J Immunol (2009) 1.33
B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis. Immunology (1997) 1.29
The major outer membrane protein of a single Chlamydia trachomatis serovar can possess more than one serovar-specific epitope. Infect Immun (1996) 1.18
Antibody recognition of a neutralization epitope on the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1994) 1.14
Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4(+) type 2 rather than type 1 immune response that is not protective. Infect Immun (2002) 1.06
Poliovirus hybrids expressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. trachomatis-neutralizing antibodies. Infect Immun (1995) 1.06
T-cell epitopes in variable segments of Chlamydia trachomatis major outer membrane protein elicit serovar-specific immune responses in infected humans. Infect Immun (2000) 1.02
Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes. Infect Immun (2000) 0.97
Vaccines for bacterial sexually transmitted infections: a realistic goal? Proc Natl Acad Sci U S A (1994) 0.97
Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection. Infect Immun (1997) 0.95
Characterization of a neutralizing monoclonal antibody directed at variable domain I of the major outer membrane protein of Chlamydia trachomatis C-complex serovars. Infect Immun (1993) 0.95
T lymphocyte immunity in host defence against Chlamydia trachomatis and its implication for vaccine development. Can J Infect Dis (1998) 0.94
A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic. Infect Immun (1993) 0.89
Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum. J Immunol (2014) 0.87
Characterization of the humoral response induced by a synthetic peptide of the major outer membrane protein of Chlamydia trachomatis serovar B. Infect Immun (1994) 0.87
Mimicry of a neutralizing epitope of the major outer membrane protein of Chlamydia trachomatis by anti-idiotypic antibodies. Infect Immun (1994) 0.85
Mutagenesis and functional reconstitution of chlamydial major outer membrane proteins: VS4 domains are not required for pore formation but modify channel function. Infect Immun (2001) 0.84
Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model. Vaccine (2011) 0.84
Dissociation of immune determinants of outer membrane proteins of Chlamydia psittaci strain guinea pig inclusion conjunctivitis. Infect Immun (1994) 0.83
Immunization with a peptide corresponding to chlamydial heat shock protein 60 increases the humoral immune response in C3H mice to a peptide representing variable domain 4 of the major outer membrane protein of Chlamydia trachomatis. Clin Diagn Lab Immunol (1999) 0.77
Benzylidene acylhydrazides inhibit chlamydial growth in a type III secretion- and iron chelation-independent manner. J Bacteriol (2014) 0.76
A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge. Immunology (2015) 0.76
Identification of MHCII variants associated with chlamydial disease in the koala (Phascolarctos cinereus). PeerJ (2014) 0.75
Update on Chlamydia trachomatis Vaccinology. Clin Vaccine Immunol (2017) 0.75
Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1981) 18.13
New knowledge of chlamydiae and the diseases they cause. J Infect Dis (1975) 9.35
Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. Proc Natl Acad Sci U S A (1984) 7.77
Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci U S A (1988) 6.54
Diversity of Chlamydia trachomatis major outer membrane protein genes. J Bacteriol (1987) 6.16
Strategies for epitope analysis using peptide synthesis. J Immunol Methods (1987) 5.69
Prediction of immunodominant helper T cell antigenic sites from the primary sequence. J Immunol (1987) 4.95
Antigenic analysis of the major outer membrane protein of Chlamydia spp. Infect Immun (1982) 4.82
Sequence analysis of the major outer membrane protein gene from Chlamydia trachomatis serovar L2. J Bacteriol (1986) 4.13
High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J Exp Med (1988) 3.55
Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants. Infect Immun (1989) 2.87
Structural analysis of chlamydial major outer membrane proteins. Infect Immun (1982) 2.74
Trachoma vaccine studies in monkeys. Am J Ophthalmol (1967) 2.65
Immunity to chlamydial infections of the eye. I. The role of circulatory and secretory antibodies in resistance to reinfection with guinea pig inclusion conjunctivitis. J Immunol (1973) 2.50
Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J Exp Med (1990) 2.13
The structure of T-cell epitopes. Annu Rev Immunol (1987) 1.99
Immunity to chlamydial infections of the eye. VI. Homologous neutralization of trachoma infectivity for the owl monkey conjuctivae by eye secretions from humans with trachoma. J Infect Dis (1973) 1.97
Experimental inclusion conjunctivitis in man: measurements of infectivity and resistance. JAMA (1965) 1.97
Enhancement of Chlamydia trachomatis infectious progeny by cultivation of HeLa 229 cells treated with DEAE-dextran and cycloheximide. J Clin Microbiol (1984) 1.87
The major outer membrane protein nucleotide sequence of Chlamydia trachomatis, serovar E. Nucleic Acids Res (1990) 1.70
In vitro neutralization of Chlamydia trachomatis by monovalent Fab antibody specific to the major outer membrane protein. Infect Immun (1991) 1.48
Murine MHC polymorphism and T cell specificities. Science (1989) 1.34
Nucleotide sequence of the major outer membrane protein gene from Chlamydia trachomatis serovar H. Nucleic Acids Res (1989) 1.32
The nucleotide sequence of major outer membrane protein gene of Chlamydia trachomatis serovar F. Nucleic Acids Res (1990) 1.29
A single peptide from the major outer membrane protein of Chlamydia trachomatis elicits T cell help for the production of antibodies to protective determinants. J Immunol (1991) 1.26
Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1981) 18.13
Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci U S A (1988) 6.54
Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars. Infect Immun (1989) 5.75
Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol (1987) 5.64
Chlamydiae. Annu Rev Microbiol (1980) 5.47
Antigenic analysis of the major outer membrane protein of Chlamydia spp. Infect Immun (1982) 4.82
Monoclonal antibody against a genus-specific antigen of Chlamydia species: location of the epitope on chlamydial lipopolysaccharide. Infect Immun (1984) 4.53
Chlamydia trachomatis has penicillin-binding proteins but not detectable muramic acid. J Bacteriol (1982) 4.33
Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med (1989) 4.25
Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. J Immunol (1997) 3.66
CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract. Infect Immun (1995) 3.45
Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. I. Antigenic heterogeneity between C. trachomatis and C. psittaci. J Immunol (1975) 3.41
Disulfide-mediated interactions of the chlamydial major outer membrane protein: role in the differentiation of chlamydiae? J Bacteriol (1985) 3.23
Chlamydia trachomatis-host cell interactions: role of the chlamydial major outer membrane protein as an adhesin. Infect Immun (1990) 3.13
Neutralization of Chlamydia trachomatis infectivity with antibodies to the major outer membrane protein. Infect Immun (1982) 3.09
Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein. J Exp Med (1989) 3.03
Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants. Infect Immun (1989) 2.87
Structural analysis of chlamydial major outer membrane proteins. Infect Immun (1982) 2.74
Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun (1995) 2.55
Immunity to murine Chlamydia trachomatis genital tract reinfection involves B cells and CD4(+) T cells but not CD8(+) T cells. Infect Immun (2000) 2.53
Pathogenesis of trachoma: the stimulus for inflammation. J Immunol (1987) 2.34
Cloning and sequence analysis of the major outer membrane protein genes of two Chlamydia psittaci strains. Infect Immun (1989) 2.32
Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice. Infect Immun (1997) 2.26
Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial-conjunctivitis in guinea pigs. Proc Natl Acad Sci U S A (1986) 2.24
Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae. J Exp Med (1998) 2.19
Identification and characterization of T helper cell epitopes of the major outer membrane protein of Chlamydia trachomatis. J Exp Med (1990) 2.13
Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. J Immunol (1999) 2.06
Differential effect of trypsin on infectivity of Chlamydia trachomatis: loss of infectivity requires cleavage of major outer membrane protein variable domains II and IV. Infect Immun (1988) 1.89
Enhancement of Chlamydia trachomatis infectious progeny by cultivation of HeLa 229 cells treated with DEAE-dextran and cycloheximide. J Clin Microbiol (1984) 1.87
A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells. Proc Natl Acad Sci U S A (1996) 1.87
Expression of the chlamydial genus-specific lipopolysaccharide epitope in Escherichia coli. Science (1985) 1.85
Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc Natl Acad Sci U S A (2001) 1.85
Tear and serum antibody response to Chlamydia trachomatis antigens during acute chlamydial conjunctivitis in monkeys as determined by immunoblotting. Infect Immun (1987) 1.76
Antigenic analysis of Chlamydiae by two-dimensional immunoelectrophoresis. II. A trachoma-LGV-specific antigen. J Immunol (1975) 1.73
Partial amino acid sequence and molecular cloning of the encoding gene for the major outer membrane protein of Chlamydia trachomatis. Infect Immun (1985) 1.63
Immunoassay for detecting Chlamydia trachomatis major outer membrane protein. J Clin Microbiol (1983) 1.61
The effect of doxycycline treatment on the development of protective immunity in a murine model of chlamydial genital infection. J Infect Dis (1999) 1.58
Reticulate bodies as single antigen in Chlamydia trachomatis serology with microimmunofluorescence. J Clin Microbiol (1979) 1.50
In vitro neutralization of Chlamydia trachomatis by monovalent Fab antibody specific to the major outer membrane protein. Infect Immun (1991) 1.48
Chlamydial infection in inducible nitric oxide synthase knockout mice. Infect Immun (1998) 1.47
Workshop on in vitro neutralization of Chlamydia trachomatis: summary of proceedings. J Infect Dis (1993) 1.44
The interaction of Chlamydia trachomatis with host cells: ultrastructural studies of the mechanism of release of a biovar II strain from HeLa 229 cells. J Infect Dis (1985) 1.44
Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in Chlamydia-infected mice. J Immunol (1998) 1.40
Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis. Infect Immun (1999) 1.35
Molecular characterization of Chlamydia trachomatis and Chlamydia psittaci plasmids. Infect Immun (1986) 1.35
The nucleotide sequence of major outer membrane protein gene of Chlamydia trachomatis serovar F. Nucleic Acids Res (1990) 1.29
Oral immunization with chlamydial major outer membrane protein (MOMP). Invest Ophthalmol Vis Sci (1988) 1.25
Neither interleukin-6 nor inducible nitric oxide synthase is required for clearance of Chlamydia trachomatis from the murine genital tract epithelium. Infect Immun (1998) 1.23
Purification of a Chlamydia trachomatis-specific antigen by immunoadsorption with monospecific antibody. J Immunol (1977) 1.22
Multiple tandem promoters of the major outer membrane protein gene (omp1) of Chlamydia psittaci. Infect Immun (1990) 1.11
Effect of proteolytic cleavage of surface-exposed proteins on infectivity of Chlamydia trachomatis. Infect Immun (1985) 1.11
Kinetics of chlamydial antigen processing and presentation to T cells by paraformaldehyde-fixed murine bone marrow-derived macrophages. Infect Immun (1995) 1.10
Identification of a Mycobacterium leprae specific protein antigen(s) and its possible application for the serodiagnosis of leprosy. Int J Lepr Other Mycobact Dis (1979) 1.09
Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants. Infect Immun (2001) 1.08
Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: implications for development of live attenuated chlamydial vaccine strains. Infect Immun (2000) 1.07
Expression of Fc gamma RIII on HeLa 229 cells: possible effect on in vitro neutralization of Chlamydia trachomatis. Infect Immun (1991) 1.07
Expression of genes encoding Th1 cell-activating cytokines and lymphoid homing chemokines by chlamydia-pulsed dendritic cells correlates with protective immunizing efficacy. Infect Immun (2001) 1.06
Poliovirus hybrids expressing neutralization epitopes from variable domains I and IV of the major outer membrane protein of Chlamydia trachomatis elicit broadly cross-reactive C. trachomatis-neutralizing antibodies. Infect Immun (1995) 1.06
Serologic diagnosis of Lymphogranuloma venereum by counterimmunoelectrophoresis with a Chlamydia trachomatis protein antigen. J Immunol (1977) 1.01
Immune responses in patients with gliomas. Surg Neurol (1974) 0.98
The low-molecular-mass, cysteine-rich outer membrane protein of Chlamydia trachomatis possesses both biovar- and species-specific epitopes. Infect Immun (1987) 0.97
A poliovirus hybrid expressing a neutralization epitope from the major outer membrane protein of Chlamydia trachomatis is highly immunogenic. Infect Immun (1993) 0.89
Sulfated polysaccharides and a synthetic sulfated polymer are potent inhibitors of Chlamydia trachomatis infectivity in vitro but lack protective efficacy in an in vivo murine model of chlamydial genital tract infection. Infect Immun (1998) 0.85
Chlamydial hemagglutinin identified as lipopolysaccharide. J Bacteriol (1987) 0.84
Studies of the role of Dermacentor occidentalis in the transmission of bovine chlamydial abortion. Infect Immun (1973) 0.79
Immunochemical and structural integrity of surface protein antigens of mycobacteria during separation from armadillo liver tissue. Int J Lepr Other Mycobact Dis (1979) 0.75